2015
DOI: 10.1101/gr.186114.114
|View full text |Cite
|
Sign up to set email alerts
|

INTEGRATE: gene fusion discovery using whole genome and transcriptome data

Abstract: While next-generation sequencing (NGS) has become the primary technology for discovering gene fusions, we are still faced with the challenge of ensuring that causative mutations are not missed while minimizing false positives. Currently, there are many computational tools that predict structural variations (SV) and gene fusions using whole genome (WGS) and transcriptome sequencing (RNA-seq) data separately. However, as both WGS and RNA-seq have their limitations when used independently, we hypothesize that the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
77
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 113 publications
(79 citation statements)
references
References 44 publications
(49 reference statements)
2
77
0
Order By: Relevance
“…Although both DNA and RNA data have limitations when it comes to detecting fusions, we found that a combination of the two data types reduced the noise inherent to each approach. This is in agreement with recent studies that combine DNA and RNA evidence to improve detection of gene fusions (49,50).…”
Section: Discussionsupporting
confidence: 93%
“…Although both DNA and RNA data have limitations when it comes to detecting fusions, we found that a combination of the two data types reduced the noise inherent to each approach. This is in agreement with recent studies that combine DNA and RNA evidence to improve detection of gene fusions (49,50).…”
Section: Discussionsupporting
confidence: 93%
“…Finally, GRIDSS was run on DNA-seq data from the HCC1395 breast cancer cell line and results compared to the published genomic breakpoints, which were predicted to be associated with "validated" fusion genes (Zhang et al 2016). GRIDSS showed strong concordance with the published results (Supplemental Table S3).…”
Section: Application To Cancer Samplessupporting
confidence: 55%
“…Transcriptome analysis via RNA-seq is thus superior to gene panel or exomesequencing methods for detection of gene fusions [56]. However, the combination of WGS + RNA-seq with subsequent split-read analysis of sequencing reads [57] appears to be ideal for unbiased detection of break point at the genomic level [58] as well as their transcriptomic consequences [59]. It should be noted that chimeric RNAs of two genes are not necessarily associated with genomic rearrangements and/or disease, and some seem to have biological relevance [60,61].…”
Section: The 'Targetome' -What To Sequence?mentioning
confidence: 99%